Cell

Sana Biotechnology Announces Positive Clinical Results in Type 1 Diabetes Study of Pancreatic Islet Cell Transplantation Without Immunosuppression Released by Sana.com on January 7, 2025. Sana Biotechnology, Inc., a company …

[00:00:00] Scott K. Johnson: I’m excited to introduce Stefany Shaheen, Chief Strategy Officer of Advanced Regenerative Manufacturing Institute, or ARMI. And BioFab USA, a program of ARMI. Stefany’s background is …

Approximately 8 million people worldwide have type 1 diabetes (T1D). It is a chronic autoimmune disease in which the body attacks and destroys its own insulin-producing beta cells (pronounced “beta”) …